YOLFTbeta
10

GeneMatrix Inc

109820 · KQ · Healthcare / Diagnostics & Research

1,335.00KRW+27.00 (+2.06%)

Price History

Full chart

Market Stats

Previous Close1,308.00
Open1,308.00
Day Range1,308.00 – 1,339.00
52-Week Range1,201.00 – 2,795.00
Volume14.19K
Market Cap30.76B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta1.06
50-Day Avg1,531.98
200-Day Avg1,921.66

About

GeneMatrix Inc. develops diagnostic products for various diseases in the field of molecular diagnostics. The company offers products for hepatitis B, hepatitis C, cervical cancer, sexually transmitted infections, respiratory infections, and gastrointestinal infections; vaccines for preventing various diseases; and new natural pharmaceutical materials for health enhancement and treatment. It also provides biochemical diagnostics, such as special chemistry and general chemistry, that includes semi and full auto analyer, and calibrators and controls. The company was founded in 2000 and is headquartered in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Soook Kim
  • Employees0
  • HeadquartersKorea Bio Park B-Wing, Seongnam-si, South Korea, 463-400, Korea
  • Websitehttps://www.genematrix.net

Leadership

  • Mr. Soook KimPresident & CEO · b. 1960
  • Sun-Pyo HongSenior Managing Director and Executive Director · b. 1968
  • Suk-Joon KimSenior Managing Director and Executive Director · b. 1967

Financials

Income Statement

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue9.98B8.06B7.29B6.68B5.32B5.08B5.19B4.73B5.05B15.90B12.11B11.21B9.81B10.02B10.64B
Growth (%)--19.30%-9.51%-8.43%-20.39%-4.43%+2.15%-8.75%+6.66%+214.85%-23.87%-7.37%-12.48%+2.08%+6.23%
Cost of Revenue5.40B4.52B3.52B3.32B2.96B3.15B3.33B2.98B3.26B4.64B6.24B6.07B4.91B4.21B4.31B
Gross Profit---2.98B2.36B1.93B1.86B1.76B1.79B11.26B5.87B5.15B4.90B5.81B6.33B
Gross Margin---44.59%44.35%38.00%35.79%37.08%35.39%70.83%48.49%45.91%49.97%58.02%59.48%
Operating Expense---4.30B4.74B6.00B3.62B4.96B4.02B8.90B7.10B6.67B7.45B7.45B7.01B
Operating Income----1.32B-2.38B-4.07B-1.76B-3.21B-2.23B2.36B-1.23B-1.52B-2.55B-1.64B-679.13M
Operating Margin----19.80%-44.86%-80.05%-33.96%-67.72%-44.13%14.84%-10.12%-13.58%-25.96%-16.39%-6.38%
EBITDA------------7.48B-172.27M-3.00B-1.17B
EBITDA Margin------------66.74%-1.76%-29.90%-11.01%
Net Income----1.12B-2.02B-3.78B-1.47B-3.11B-1.37B8.03B-987.68M-8.11B-894.94M-3.75B-1.83B
Net Income Margin----16.82%-38.01%-74.35%-28.32%-65.61%-27.06%50.50%-8.16%-72.33%-9.12%-37.41%-17.24%
R&D1.46B-1.95B1.75B2.07B1.90B2.01B2.16B-4.80B3.01B2.68B3.47B3.29B2.77B
R&D as % of Total Revenue14.63%-26.74%26.28%38.86%37.32%38.65%45.69%-30.18%24.89%23.86%35.31%32.81%26.07%
Interest Expense000000000221.65M77.58M100.54M138.04M160.28M115.92M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.39%0.64%0.90%1.41%1.60%1.09%

Balance Sheet

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets22.62B20.35B19.68B17.05B20.78B19.33B17.74B31.52B28.46B38.17B39.53B31.90B31.35B28.46B27.27B
Total Liabilities6.88B6.43B6.90B5.16B10.74B6.85B6.68B20.68B13.21B4.78B7.21B7.72B8.21B9.23B9.80B
Total Equity14.18B12.51B11.25B10.23B8.68B12.48B11.06B10.83B15.25B33.39B32.32B24.19B23.15B19.23B17.47B
Cash3.67B3.50B3.13B866.24M3.68B1.23B1.26B5.36B7.08M9.03M5.27M3.54M2.73M4.85M2.27B
Total Debt-------7.82B3.64B3.64B-----
Net Debt--------4.87B---1.43B1.74B1.33B

Cash Flow

Currency: KRW2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow----1.38B-591.96M-373.25M-1.77B-2.74B-2.28B4.51B3.37B-1.02B-2.35B-200.12M1.29B
Investing Cash Flow----347.37M-2.42B-2.27B1.73B-9.51B4.71B1.27B-780.37M-6.97B-446.43M-372.95M-
Financing Cash Flow2.22B195.79M57.20M-543.21M5.82B189.66M90.88M16.36B-1.83B-1.95B-123.21M83.05M171.62M163.02M-
Capital Expenditure1.82B230.82M176.45M263.90M78.90M270.95M181.76M344.50M191.44M366.56M258.22M172.88M161.20M33.67M64.54M
Free Cash Flow---------4.14B3.11B-1.20B-2.51B-233.79M1.23B
FCF to OCF---------91.87%92.34%116.89%106.87%116.82%95.00%

Earnings

Report DateMar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------------------------------------
EPS Actual8.0224.007.00-5.759.72-71.44-6.01-13.262.61-24.38-130.15-27.05-20.96-27.18-44.41-39.28-19.82-10.03-20.56-31.54-46.00-28.07-55.33-32.86-41.33-27.33-160.43-29.30-15.13-26.47-25.02-54.91-35.39-48.48-61.12-48.73-23.515.18-13.727.01280.4088.2230.4937.09114.30-8.74-192.11-197.94-15.77-38.18-154.40-52.21-48.7965.69-9.52-92.60-63.37-9.69-17.53-39.39-19.5613.31-46.25-11.0834.50
Surprise-----------------------------------------------------------------
Timing-----------------------------------------------------------------

Key Statistics & Ratios

Market Cap30.76B
Enterprise Value19.03B
Trailing P/E0.00
Forward P/E0.00
Price / Sales6.52
Price / Book1.77
Revenue (TTM)4.72B
Gross Profit (TTM)1.79B
EBITDA-2.14B
Profit Margin-44.33%
Operating Margin-45.79%
Return on Equity-15.62%
Return on Assets-6.05%
Shares Outstanding19.96M
Shares Float14.96M
Beta1.06
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 24, 20183:2
  • Apr 10, 20142:1